Amarantus Provides Update on Capital Restructuring and Announces Participation in RESI JPM 2018
09. Januar 2018 10:59 ET
|
Amarantus Bioscience Holdings, Inc.
Convertible securities holders grant 45-day extension to complete Tender Exchange Elto Pharma recruiting seasoned management to lead "Go-Public" transaction Management...